Nitric Oxide Mediates Inflammation in Type II Diabetes Mellitus through the PPARγ/eNOS Signaling Pathway

Table 1

Clinical data in the T2DM group and control group.

	T2DM ()			Control ()
Age (yrs)	34-50			32-51
Gender (M/F)	34/21			30/20
Plasma nitrite (μM)						<0.0001
Plasma nitrate (μM)						<0.0001
	M	F		M	F
Plasma nitrite (μM)			0.2785			0.5689
Plasma nitrate (μM)			0.5431			0.5408